Making Science Group, S.A. (BME:MAKS)
5.45
0.00 (0.00%)
Nov 16, 2026, 9:52 AM CET
Making Science Group Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 367.35 | 348.29 | 271.32 | 235.77 | 210.13 | 110.45 | |
Revenue Growth | 18.51% | 28.37% | 15.08% | 12.20% | 90.26% | 91.51% |
Cost of Revenue | 343.25 | 326.12 | 246.63 | 214.71 | 188.55 | 101.71 |
Gross Profit | 24.1 | 22.17 | 24.7 | 21.05 | 21.58 | 8.74 |
Selling, General & Admin | - | - | - | - | - | 9.26 |
Other Operating Expenses | 16.84 | 14.8 | 14.93 | 13.4 | 14.05 | -2.53 |
Operating Expenses | 24.29 | 21.98 | 21.01 | 20.33 | 18.06 | 10.56 |
Operating Income | -0.19 | 0.19 | 3.68 | 0.72 | 3.52 | -1.82 |
Interest Expense | -3.5 | -4.29 | -5.32 | -4.9 | -2.09 | -0.79 |
Interest & Investment Income | 0.07 | 0.26 | 1.11 | 0.34 | 0.05 | - |
Earnings From Equity Investments | - | - | - | -0 | 0 | 0.01 |
Currency Exchange Gain (Loss) | -0.51 | -0.18 | -0.92 | 0.43 | -1.13 | -0.3 |
Other Non Operating Income (Expenses) | - | - | - | - | - | 0.03 |
EBT Excluding Unusual Items | -4.12 | -4.02 | -1.45 | -3.41 | 0.35 | -2.87 |
Impairment of Goodwill | -2.53 | -2.53 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.02 |
Asset Writedown | -0.13 | -0.13 | - | - | - | - |
Other Unusual Items | - | - | - | - | 0.62 | 0.35 |
Pretax Income | -6.79 | -6.68 | -1.45 | -3.41 | 0.97 | -2.54 |
Income Tax Expense | 0.95 | 0.91 | 0.77 | 0.71 | 1.48 | 0.66 |
Earnings From Continuing Operations | -7.74 | -7.59 | -2.22 | -4.12 | -0.51 | -3.2 |
Earnings From Discontinued Operations | 31.49 | 32.6 | 0.78 | - | - | - |
Net Income to Company | 23.75 | 25.01 | -1.44 | -4.12 | -0.51 | -3.2 |
Minority Interest in Earnings | -0.01 | -0.18 | -0.28 | 0.02 | -0.39 | -0.29 |
Net Income | 23.74 | 24.83 | -1.72 | -4.09 | -0.91 | -3.49 |
Net Income to Common | 23.74 | 24.83 | -1.72 | -4.09 | -0.91 | -3.49 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 9 | 9 | 9 | 8 | 8 | 8 |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 8 | 8 | 8 |
Shares Change | -0.57% | 1.27% | 3.85% | 3.10% | 7.19% | 11.54% |
EPS (Basic) | 2.67 | 2.83 | -0.20 | -0.49 | -0.11 | -0.46 |
EPS (Diluted) | 2.67 | 2.83 | -0.20 | -0.49 | -0.11 | -0.46 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 24.92 | 38.38 | 0.05 | -1.49 | 10.56 | 6.54 |
Free Cash Flow Per Share | 2.80 | 4.37 | 0.01 | -0.18 | 1.30 | 0.86 |
Dividend Per Share | 0.222 | 0.222 | - | - | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 6.56% | 6.37% | 9.10% | 8.93% | 10.27% | 7.91% |
Operating Margin | -0.05% | 0.05% | 1.36% | 0.31% | 1.68% | -1.65% |
Profit Margin | 6.46% | 7.13% | -0.63% | -1.74% | -0.43% | -3.16% |
Free Cash Flow Margin | 6.78% | 11.02% | 0.02% | -0.63% | 5.03% | 5.92% |
EBITDA | -2.83 | 0.91 | 4.23 | 1.41 | 4.02 | 1.22 |
EBITDA Margin | -0.77% | 0.26% | 1.56% | 0.60% | 1.91% | 1.10% |
D&A For EBITDA | -2.64 | 0.72 | 0.55 | 0.69 | 0.5 | 3.04 |
EBIT | -0.19 | 0.19 | 3.68 | 0.72 | 3.52 | -1.82 |
EBIT Margin | -0.05% | 0.05% | 1.36% | 0.31% | 1.68% | -1.65% |
Effective Tax Rate | - | - | - | - | 152.93% | - |